精优药业控股有限公司（股票代码：00858）于2026年5月6日发布截至2026年4月30日的证券变动月报表。公告显示，公司本月底注册股本维持20,000,000,000股，面值每股0.01港元，注册股本总额为200,000,000港元，与上月无变化。
已发行股份方面，公司在报告期内从上月底的2,550,000,000股增至2,900,000,000股，净增350,000,000股。公告显示，上述增发主要源于部分2033年到期的零息可换股债券转换，转换价为每股0.6413港元。报告期内不存在公司回购或注销股份的情况。公司股权激励相关的购股权计划项下的购股权数量保持不变，月末潜在可发行股份合计162,500,000股。
截至本月末，公司确认其符合香港联合交易所有限公司的相关上市规则及法规要求。公告由公司执行董事及公司秘书王秀娟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.